Verywell Health on MSN

What to know about immune thrombocytopenia (ITP) and COVID-19

Medically reviewed by Gagandeep Brar, MD Key Takeaways ITP does not increase the risk of getting or having severe ...
Yahoo Finance

Press Release: Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia

Approval based on the LUNA 3 phase 3 study that demonstrated rapid and durable platelet response and improvements in other ITP symptoms ITP is a rare disease of complex immune dysregulation leading to ...
Monthly Prescribing Reference

Ianalumab Significantly Prolongs Time to Treatment Failure in Primary ITP

The addition of ianalumab to eltrombopag significantly prolonged the duration of safe platelet levels. Ianalumab added to eltrombopag significantly prolonged the time to treatment failure (TTF) in ...